Search

Your search keyword '"Lauren, Christine"' showing total 499 results

Search Constraints

Start Over You searched for: Author "Lauren, Christine" Remove constraint Author: "Lauren, Christine"
499 results on '"Lauren, Christine"'

Search Results

57. Structural and chemical characterization of responsive nanocrystalline materials

59. Epilepsy: Epilepsy: Level 4 — Efficacious and Specific for SMR-based and SCP-based Neurofeedback for Seizure; Level 3 — Probably Efficacious for SMR-based Neurofeedback for Nonseizure Manifestations of Epilepsy; Level 1 — Not Empirically Supported for Connectivity-based Neurofeedback

64. Logistic Regression: Odds & Ends

65. Characterization of wound microbes in epidermolysis bullosa: Results from the epidermolysis bullosa clinical characterization and outcomes database

67. Contributors

76. Fostering Positive Emotions: Shifting Organizations’ Cultures to Value Well-Being

80. Systemic immunosuppressive therapy for inflammatory skin diseases in children: Expert consensus‐based guidance for clinical decision‐making during the COVID‐19 pandemic

83. Safety and efficacy of retreatment with immune checkpoint inhibitors (ICIs) in patients with metastatic RCC (mRCC) who have previously received an ICI.

84. Conditional immune adverse event rate in urothelial and renal cell carcinoma patients treated with immune checkpoint inhibitors.

85. Real-world evidence of the impact of prior antibiotic exposure on immune checkpoint inhibitor outcomes in patients with metastatic urothelial cancer.

86. Outcomes of patients with pancreatic-only oligometastatic renal cell carcinoma (RCC).

87. Circulating immune cell populations and cytokines in patients with metastatic variant histology renal cell carcinoma (vRCC) treated with atezolizumab plus bevacizumab (AB): Dynamic changes on therapy and association with outcomes from a phase II trial.

88. Adenosine receptor blockade with ciforadenant +/- atezolizumab in advanced metastatic castration-resistant prostate cancer (mCRPC).

89. Clinical outcomes of abiraterone acetate + prednisone (AA) + bone resorption inhibitors (BRI) versus AA alone as first-line therapy for castration-resistant prostate cancer (CRPC) with bone metastases (BM) in an international multicenter database.

91. Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome

93. Atopic Dermatitis

94. Contributors

98. Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa

100. Impact of timing of adjuvant chemotherapy following radical cystectomy for bladder cancer on patient survival

Catalog

Books, media, physical & digital resources